Back

Dynamics of infection-elicited SARS-CoV-2 antibodies in children over time

Gentles, L. E.; Kehoe, L.; Crawford, K. H.; Lacombe, K.; Dickerson, J.; Wolf, C.; Yuan, J.; Schuler, S.; Watson, J. T.; Nyanseor, S.; Briggs-Hagen, M.; Saydah, S.; Midgley, C. M.; Pringle, K.; Chu, H. Y.; Bloom, J. D.; Englund, J. E.

2022-01-25 infectious diseases
10.1101/2022.01.14.22269235 medRxiv
Show abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection elicits an antibody response that targets several viral proteins including spike (S) and nucleocapsid (N); S is the major target of neutralizing antibodies. Here, we assess levels of anti-N binding antibodies and anti-S neutralizing antibodies in unvaccinated children compared with unvaccinated older adults following infection. Specifically, we examine neutralization and anti-N binding by sera collected up to 52 weeks following SARS-CoV-2 infection in children and compare these to a cohort of adults, including older adults, most of whom had mild infections that did not require hospitalization. Neutralizing antibody titers were lower in children than adults early after infection, but by 6 months titers were similar between age groups. The neutralizing activity of the childrens sera decreased modestly from one to six months; a pattern that was not significantly different from that observed in adults. However, infection of children induced much lower levels of anti-N antibodies than in adults, and levels of these anti-N antibodies decreased more rapidly in children than in adults, including older adults. These results highlight age-related differences in the antibody responses to SARS-CoV-2 proteins and, as vaccines for children are introduced, may provide comparator data for the longevity of infection-elicited and vaccination-induced neutralizing antibody responses.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
JCI Insight
277 papers in training set
Top 0.1%
28.1%
2
mBio
833 papers in training set
Top 2%
7.8%
3
The Journal of Infectious Diseases
202 papers in training set
Top 0.5%
6.2%
4
Clinical Infectious Diseases
235 papers in training set
Top 0.4%
6.2%
5
Journal of the Pediatric Infectious Diseases Society
10 papers in training set
Top 0.1%
5.4%
50% of probability mass above
6
Science Translational Medicine
127 papers in training set
Top 0.4%
4.8%
7
Journal of Clinical Investigation
179 papers in training set
Top 1.0%
4.3%
8
Microbiology Spectrum
469 papers in training set
Top 5%
2.6%
9
eBioMedicine
183 papers in training set
Top 2%
2.1%
10
Open Forum Infectious Diseases
142 papers in training set
Top 2%
1.7%
11
Journal of Clinical Microbiology
130 papers in training set
Top 0.8%
1.7%
12
Med
39 papers in training set
Top 0.3%
1.5%
13
eLife
5828 papers in training set
Top 52%
1.5%
14
mSphere
302 papers in training set
Top 5%
1.4%
15
PLOS ONE
5266 papers in training set
Top 52%
1.4%
16
JAMA Network Open
130 papers in training set
Top 3%
1.3%
17
Influenza and Other Respiratory Viruses
46 papers in training set
Top 0.6%
1.1%
18
Nature Communications
5641 papers in training set
Top 54%
1.0%
19
Cell Reports Medicine
153 papers in training set
Top 4%
1.0%
20
Clinical & Translational Immunology
22 papers in training set
Top 0.3%
1.0%
21
iScience
1154 papers in training set
Top 31%
1.0%
22
PLOS Pathogens
820 papers in training set
Top 9%
0.8%
23
Frontiers in Immunology
638 papers in training set
Top 11%
0.6%
24
Science
477 papers in training set
Top 10%
0.6%
25
Journal of Clinical Virology
63 papers in training set
Top 1.0%
0.6%
26
The Journal of Immunology
166 papers in training set
Top 3%
0.6%
27
Emerging Infectious Diseases
105 papers in training set
Top 2%
0.6%